首页> 外文期刊>The Lancet >Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
【24h】

Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.

机译:基因型对囊性纤维化表型和死亡率的影响:一项回顾性队列研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of CFTR genotype on mortality and disease phenotype. METHODS: Using the US Cystic Fibrosis Foundation National Registry, we did a retrospective cohort study to compare standardised mortality rates for the 11 most common genotypes heterozygous for DeltaF508 with those homozygous for DeltaF508. Of the 28455 patients enrolled in the registry at the time of our analysis, 17853 (63%) were genotyped. We also compared the clinical phenotype, including lung function, age at diagnosis, and nutritional measures, of 22 DeltaF508 heterozygous genotypes. Mortality rates and clinical phenotype were also compared between genotypes classified into six classes on the basis of their functional effect on CFTR production. FINDINGS: Between 1991 and 1999, genetic and clinical data were available for 17853 patients with cystic fibrosis, which was 63% of the total cohort. There were 1547 deaths during the 9 years of follow-up. In the analysis of the 11 most common genotypes, DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/3849+10kbC-->T, and DeltaF508/2789+5G-->A had a significantly lower mortality rate (4.7, 8.0, 11.9, and 4.4, respectively) than the genotype homozygous for DeltaF508 (21.8, p=0.0060). DeltaF508/R117H, DeltaF508/DeltaI507, DeltaF508/ 3849+10 kbC-->T, DeltaF508/2789+5G-->A, and DeltaF508/A455E have a milder clinical phenotype. Outcomes for all functional classes were compared with that of class II (containing DeltaF508 homozygotes) and classes IV and V had a significantly lower mortality rate and milder clinical phenotype. INTERPRETATION: Patients with cystic fibrosis have distinct genetic subgroups that are associated with mild clinical manifestations and low mortality. These differences in phenotype are also related to the functional classification of CFTR genotype.
机译:背景:已鉴定出导致囊性纤维化的囊性纤维化跨膜电导调节基因(CFTR)的1000多种突变。我们检查了CFTR基因型对死亡率和疾病表型的影响。方法:使用美国囊性纤维化基金会国家注册局进行的回顾性队列研究,比较了DeltaF508和DeltaF508的11种最常见基因型杂合子的标准死亡率。在我们进行分析时,登记的28455例患者中,有17853例(63%)具有基因型。我们还比较了22种DeltaF508杂合基因型的临床表型,包括肺功能,诊断年龄和营养指标。根据它们对CFTR产生的功能影响,还比较了分为6类的基因型的死亡率和临床表型。结果:在1991年至1999年之间,获得了17853例囊性纤维化患者的遗传和临床数据,占总队列的63%。在接下来的9年中,有1547人死亡。在分析11种最常见的基因型时,DeltaF508 / R117H,DeltaF508 / DeltaI507,DeltaF508 / 3849 + 10kbC-> T和DeltaF508 / 2789 + 5G-> A的死亡率显着降低(4.7、8.0、11.9分别比DeltaF508的基因型纯正(21.8,p = 0.0060)。 DeltaF508 / R117H,DeltaF508 / DeltaI507,DeltaF508 / 3849 + 10 kbC-> T,DeltaF508 / 2789 + 5G-> A和DeltaF508 / A455E具有较温和的临床表型。将所有功能类别的结果与II类(包含DeltaF508纯合子)的结果进行比较,IV和V类的死亡率显着降低,临床表型更温和。囊性纤维化患者具有不同的遗传亚组,与轻度临床表现和低死亡率相关。这些表型上的差异也与CFTR基因型的功能分类有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号